OPTIME-CHF

OPTIME-CHF

Cardiology A clinical trial–Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure
Mentioned in ?
References in periodicals archive ?
Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Admission or changes in renal function during hospitalization for worsening heart failure predict post discharge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
Ayaktan izlenen hastalarda hiponatreminin kotu prognostik gosterge oldugu ile ilgili cok sayida calisma olmakla birlikte hastanede yatan hastalarda hiponatreminin mortalite uzerinde olumsuz etkilerini arastiran sinirli sayidaki calismalar icin den en genis vaka sayili calismalardan biri OPTIME-CHF calismasinin alt grup analizidir (22).
The society recommends against the routine use of intravenous inotropes in patients hospitalized with acutely decompensated heart failure, based largely on results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).